Artesunate-Nanoliposome-TPP, a Novel Drug Delivery System That Targets the Mitochondria, Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Oxidative Stress and Inflammatory Effects

References

• Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756–766. doi:10.1016/s0140-6736(11)61454-2
   PubMed Web of Science ®Google Scholar
• Al-Jaghbeer M, Dealmeida D, Bilderback A, Ambrosino R, Kellum JA. Clinical decision support for in-hospital AKI. J Am Soc Nephrol. 2018;29(2):654–660. doi:10.1681/asn.2017070765
   PubMed Web of Science ®Google Scholar
• Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med. 2015;41(8):1411–1423. doi:10.1007/s00134-015-3934-7
   PubMed Web of Science ®Google Scholar
• Li HD, Meng XM, Huang C, Zhang L, Lv XW, Li J. Application of herbal traditional Chinese medicine in the treatment of acute kidney injury. Front Pharmacol. 2019;10:376. doi:10.3389/fphar.2019.00376
   PubMed Web of Science ®Google Scholar
• Kellum JA, Chawla LS, Keener C, et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med. 2016;193(3):281–287. doi:10.1164/rccm.201505-0995OC
   PubMed Web of Science ®Google Scholar
• Linkermann A. Nonapoptotic cell death in acute kidney injury and transplantation. Kidney Int. 2016;89(1):46–57. doi:10.1016/j.kint.2015.10.008
   PubMed Web of Science ®Google Scholar
• Waikar SS, Liu KD, Chertow GM. Diagnosis, epidemiology and outcomes of acute kidney injury. Clin J Am Soc Nephrol. 2008;3(3):844–861. doi:10.2215/cjn.05191107
   PubMed Web of Science ®Google Scholar
• Wang W, Chen J, Hu D, et al. SARS-CoV-2 N protein induces acute kidney injury via Smad3-dependent G1 cell cycle arrest mechanism. Adv Sci. 2022;9(3):e2103248. doi:10.1002/advs.202103248
   Web of Science ®Google Scholar
• Aloy B, Janus N, Isnard-Bagnis C, Deray G, Launay-Vacher V. Renal toxicity of anticancer drugs. Nephrol Ther. 2021;17(7):553–563. doi:10.1016/j.nephro.2021.09.001
   PubMed Web of Science ®Google Scholar
• Liu S, Zhao J, Wang F. Acute kidney injury in cancer patients. Clin Exp Nephrol. 2022;26(2):103–112. doi:10.1007/s10157-021-02131-7
   PubMed Web of Science ®Google Scholar
• Rosner MH, Perazella MA, Ingelfinger JR. Acute kidney injury in patients with cancer. N Engl J Med. 2017;376(18):1770–1781. doi:10.1056/NEJMra1613984
   PubMed Web of Science ®Google Scholar
• Ghosh S. Cisplatin: the first metal based anticancer drug. Bioorg Chem. 2019;88:102925. doi:10.1016/j.bioorg.2019.102925
   PubMed Web of Science ®Google Scholar
• Ojha S, Venkataraman B, Kurdi A, Mahgoub E, Sadek B, Rajesh M. Plant-derived agents for counteracting cisplatin-induced nephrotoxicity. Oxid Med Cell Longev. 2016;2016:4320374. doi:10.1155/2016/4320374
   PubMed Web of Science ®Google Scholar
• Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int. 2008;73(9):994–1007. doi:10.1038/sj.ki.5002786
   PubMed Web of Science ®Google Scholar
• Fang CY, Lou DY, Zhou LQ . Natural products: potential treatments for cisplatin-induced nephrotoxicity. Acta Pharmacol Sin. 2021;42(12):1951–1969. doi:10.1038/s41401-021-00620-9
   PubMed Web of Science ®Google Scholar
• Li J, Wu Y, Chen C, Zhang, W, Yue, L, Liu, T, et al. A systematic review for prevention of cisplatin-induced nephrotoxicity using different hydration protocols and meta-analysis for magnesium hydrate supplementation. Clin Exp Nephrol. 2024;28(1):1–12. doi:10.1007/s10157-023-02386-2
   PubMedGoogle Scholar
• Fukushima K, Futatsugi A, Maekawa M, Naito S, Okada A, Sugioka N. Comparison of cisplatin-induced nephrotoxicity between single-dose and split-dose administration to rats. Biomed Pharmacother. 2022;147:112619. doi:10.1016/j.biopha.2022.112619
   PubMed Web of Science ®Google Scholar
• Darwish MA, Abo-Youssef AM, Khalaf MM, Abo-Saif AA, Saleh IG, Abdelghany TM. Resveratrol influences platinum pharmacokinetics: a novel mechanism in protection against cisplatin-induced nephrotoxicity. Toxicol Lett. 2018;290:73–82. doi:10.1016/j.toxlet.2018.03.023
   PubMed Web of Science ®Google Scholar
• Nakamura T, Yonezawa A, Hashimoto S, Katsura T, Inui K. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity. Biochem Pharmacol. 2010;80(11):1762–1767. doi:10.1016/j.bcp.2010.08.019
   PubMed Web of Science ®Google Scholar
• Kleih M, Böpple K, Dong M, et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 2019;10(11):851. doi:10.1038/s41419-019-2081-4
   PubMedGoogle Scholar
• Brooks C, Wei Q, Cho SG, Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 2009;119(5):1275–1285. doi:10.1172/jci37829
   PubMed Web of Science ®Google Scholar
• Klayman DL. Qinghaosu (artemisinin): an antimalarial drug from China. Science. 1985;228(4703):1049–1055. doi:10.1126/science.3887571
   PubMed Web of Science ®Google Scholar
• Dentinger CM, Rakotomanga TA, Rakotondrandriana A, et al. Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018. Malar J. 2021;20(1):432. doi:10.1186/s12936-021-03935-4
   PubMed Web of Science ®Google Scholar
• Visser MT, Zonneveld R, Peto TJ, van Vugt M, Dondorp AM, van der Pluijm RW. Are national treatment guidelines for falciparum malaria in line with WHO recommendations and is antimalarial resistance taken into consideration? - A review of guidelines in non-endemic countries. Trop Med Int Health. 2022;27(2):129–136. doi:10.1111/tmi.13715
   PubMed Web of Science ®Google Scholar
• Hess KM, Goad JA, Arguin PM. Intravenous artesunate for the treatment of severe malaria. Ann Pharmacother. 2010;44(7–8):1250–1258. doi:10.1345/aph.1M732
   PubMed Web of Science ®Google Scholar
• Shah PJ, Koshy J, Everett N, Attia E. Severe Plasmodium falciparum malaria treated with investigational artesunate in the United States. J Pharm Pract. 2020;33(1):108–112. doi:10.1177/0897190018782367
   PubMed Web of Science ®Google Scholar
• Li B, Zhang Z, Fu Y. Anti-inflammatory effects of artesunate on atherosclerosis via miR-16-5p and TXNIP regulation of the NLRP3 inflammasome. Ann Transl Med. 2021;9(20):1558. doi:10.21037/atm-21-4939
   PubMed Web of Science ®Google Scholar
• Ghosh AK, Miller H, Knox K, Kundu M, Henrickson KJ, Arav-Boger R. Inhibition of human coronaviruses by antimalarial peroxides. ACS Infect Dis. 2021;7(7):1985–1995. doi:10.1021/acsinfecdis.1c00053
   PubMed Web of Science ®Google Scholar
• Shakir L, Hussain M, Javeed A, Ashraf M, Riaz A. Artemisinins and immune system. Eur J Pharmacol. 2011;668(1–2):6–14. doi:10.1016/j.ejphar.2011.06.044
   PubMed Web of Science ®Google Scholar
• Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001;18(4):767–773. doi:10.3892/ijo.18.4.767
   PubMed Web of Science ®Google Scholar
• Lei XY, Tan RZ, Jia J, et al. Artesunate relieves acute kidney injury through inhibiting macrophagic mincle-mediated necroptosis and inflammation to tubular epithelial cell. J Cell Mol Med. 2021;25(18):8775–8788. doi:10.1111/jcmm.16833
   PubMed Web of Science ®Google Scholar
• Shen S, Liu SZ, Du MB, Ge KY, Song LH, Ye ZG. Determination of equilibrium solubility and apparent oil /water partition coefficient of artesunate. Chin J Exp Traditional Med Formulae. 2013;19(19):9–12.
   Google Scholar
• Fanello C, Hoglund RM, Lee SJ, et al. Pharmacokinetic study of rectal artesunate in children with severe malaria in Africa. Antimicrob Agents Chemother. 2021;65(4). doi:10.1128/aac.02223-20
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Liposomal drug delivery systems: from concept to clinical applications. Adv Drug Deliv Rev. 2013;65(1):36–48. doi:10.1016/j.addr.2012.09.037
   PubMed Web of Science ®Google Scholar
• Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomed. 2015;10:975–999. doi:10.2147/ijn.S68861
   PubMed Web of Science ®Google Scholar
• Amekyeh H, Alkhader E, Sabra R, Billa N. Prospects of curcumin nanoformulations in cancer management. Molecules. 2022;27(2):361. doi:10.3390/molecules27020361
   PubMed Web of Science ®Google Scholar
• Khan S, Hussain A, Attar F, et al. A review of the berberine natural polysaccharide nanostructures as potential anticancer and antibacterial agents. Biomed Pharmacother. 2022;146:112531. doi:10.1016/j.biopha.2021.112531
   PubMed Web of Science ®Google Scholar
• Quijia CR, Chorilli M. Piperine for treating breast cancer: a review of molecular mechanisms, combination with anticancer drugs, and nanosystems. Phytother Res. 2022;36(1):147–163. doi:10.1002/ptr.7291
   PubMed Web of Science ®Google Scholar
• Shen S, Du M, Liu Q, et al. Development of GLUT1-targeting alkyl glucoside-modified dihydroartemisinin liposomes for cancer therapy. Nanoscale. 2020;12(42):21901–21912. doi:10.1039/d0nr05138a
   PubMed Web of Science ®Google Scholar
• Gu L, Zhang J, Liu D, et al. Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy. J Nanobiotechnology. 2022;20(1):376. doi:10.1186/s12951-022-01569-5
   PubMed Web of Science ®Google Scholar
• Deng F, Zhang H, Zhou W, et al. TRPA1 promotes cisplatin-induced acute kidney injury via regulating the endoplasmic reticulum stress-mitochondrial damage. J Transl Med. 2023;21(1):695. doi:10.1186/s12967-023-04351-9
   PubMed Web of Science ®Google Scholar
• Radford MG, Jr., Donadio JV, Jr., Bergstralh EJ, Grande, JP, et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol. 1997;8(2):199–207. doi:10.1681/asn.V82199
   PubMed Web of Science ®Google Scholar
• Xie SB, Wang WM, Chen N. Progression of renal tubulointerstitial fibrosis and expression of α-SMA,TGF-β_1 and VDR in rat UUO models. J Shanghai Jiaotong Univ. 2010;30(7):1.
   Google Scholar
• Li W, Xu Q, He YF, et al. Anti-tumor effect of steamed codonopsis lanceolata in H22 tumor-bearing mice and its possible mechanism. Nutrients. 2015;7(10):8294–8307. doi:10.3390/nu7105395
   PubMed Web of Science ®Google Scholar
• Lingaraju MC, Pathak NN, Begum J, et al. Betulinic acid attenuates renal oxidative stress and inflammation in experimental model of murine polymicrobial sepsis. Eur J Pharm Sci. 2015;70:12–21. doi:10.1016/j.ejps.2015.01.001
   PubMed Web of Science ®Google Scholar
• Ozkok A, Ravichandran K, Wang Q, Ljubanovic D, Edelstein CL. NF-κB transcriptional inhibition ameliorates cisplatin-induced acute kidney injury (AKI). Toxicol Lett. 2016;240(1):105–113. doi:10.1016/j.toxlet.2015.10.028
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay P, Rajesh M, Pan H, et al. Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy. Free Radic Biol Med. 2010;48(3 457–467). doi:10.1016/j.freeradbiomed.2009.11.022
   PubMed Web of Science ®Google Scholar
• Hagar H, Medany AE, Salam R, Medany GE, Nayal OA. Betaine supplementation mitigates cisplatin-induced nephrotoxicity by abrogation of oxidative/nitrosative stress and suppression of inflammation and apoptosis in rats. Exp Toxicol Pathol. 2015;67(2):133–141. doi:10.1016/j.etp.2014.11.001
   PubMedGoogle Scholar
• Gu H, Gwon MG, Kim JH, Leem J, Lee SJ, Ahmed M. Oridonin attenuates cisplatin-induced acute kidney injury via inhibiting oxidative stress, apoptosis, and inflammation in mice. Biomed Res Int. 2022;2022:3002962. doi:10.1155/2022/3002962
   PubMed Web of Science ®Google Scholar
• Zaaba NE, Beegam S, Elzaki O, et al. The nephroprotective effects of α-bisabolol in cisplatin-induced acute kidney injury in mice. Biomedicines. 2022;10(4):842. doi:10.3390/biomedicines10040842
   PubMed Web of Science ®Google Scholar
• Yan X, Tan XY, Li YX, et al. A stepwise targeting curcumin derivative, Ser@TPP@CUR, for acute kidney injury. ACS Med Chem Lett. 2022;13(4):554–559. doi:10.1021/acsmedchemlett.1c00585
   PubMed Web of Science ®Google Scholar
• Hao Q, Xiao X, Zhen J, et al. Resveratrol attenuates acute kidney injury by inhibiting death receptor‑mediated apoptotic pathways in a cisplatin‑induced rat model. Mol Med Rep. 2016;14(4):3683–3689. doi:10.3892/mmr.2016.5714
   PubMed Web of Science ®Google Scholar
• Zhou L, Yu P, Wang TT, et al. Polydatin attenuates cisplatin-induced acute kidney injury by inhibiting ferroptosis. Oxid Med Cell Longev. 2022;2022:9947191. doi:10.1155/2022/9947191
   PubMed Web of Science ®Google Scholar
• Dang WZ, Li H, Jiang B, et al. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway. Phytomedicine. 2019;62:152965. doi:10.1016/j.phymed.2019.152965
   PubMed Web of Science ®Google Scholar
• Chen Q, Wang Z, Lv J, et al. Efficacy and safety of artesunate for patients with IgA nephropathy: a study protocol for a multicenter, double-blind, randomized, placebo-controlled trial. Trials. 2022;23(1):444. doi:10.1186/s13063-022-06336-3
   PubMed Web of Science ®Google Scholar
• Sun Z, Ma Y, Chen F, Wang S, Chen B, Shi J. Artesunate ameliorates high glucose-induced rat glomerular mesangial cell injury by suppressing the TLR4/NF-κB/NLRP3 inflammasome pathway. Chem Biol Interact. 2018;293:11–19. doi:10.1016/j.cbi.2018.07.011
   PubMed Web of Science ®Google Scholar
• Patra JK, Das G, Fraceto LF, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnology. 2018;16(1):71. doi:10.1186/s12951-018-0392-8
   PubMed Web of Science ®Google Scholar
• Lammers T, Ferrari M. The success of nanomedicine. Nano Today. 2020;31. doi:10.1016/j.nantod.2020.100853
   Web of Science ®Google Scholar
• Chang HI, Yeh MK. Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy. Int J Nanomed. 2012;7:49–60. doi:10.2147/ijn.S26766
   PubMed Web of Science ®Google Scholar
• Hu C, Liang K, An R, Wang XH, You LS. Tissue distribution of TPGS modified artesunate liposome and its metabolites in rats. Zhongguo Zhong Yao Za Zhi. 2018;43(2):325–331. doi:10.19540/j.cnki.cjcmm.20171023.006
   PubMedGoogle Scholar
• Karim N, Shishir MRI, Rashwan AK, Ke H, Chen W. Suppression of palmitic acid-induced hepatic oxidative injury by neohesperidin-loaded pectin-chitosan decorated nanoliposomes. Int J Biol Macromol. 2021;183:908–917. doi:10.1016/j.ijbiomac.2021.05.010
   PubMed Web of Science ®Google Scholar
• Li Y, Xu F, Li X, et al. Development of curcumin-loaded composite phospholipid ethosomes for enhanced skin permeability and vesicle stability. Int J Pharm. 2021;592:119936. doi:10.1016/j.ijpharm.2020.119936
   PubMedGoogle Scholar
• Ramesh G, Reeves WB. TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity. J Clin Invest. 2002;110(6):835–842. doi:10.1172/jci15606
   PubMed Web of Science ®Google Scholar
• Holditch SJ, Brown CN, Lombardi AM, Nguyen KN, Edelstein CL. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int J Mol Sci. 2019;20(12):3011. doi:10.3390/ijms20123011
   PubMed Web of Science ®Google Scholar
• Kim DU, Kim DG, Choi JW, et al. Loganin attenuates the severity of acute kidney injury induced by cisplatin through the inhibition of ERK activation in mice. Int J Mol Sci. 2021;22(3). doi:10.3390/ijms22031421
   Web of Science ®Google Scholar
• Faubel S, Lewis EC, Reznikov L, et al. Cisplatin-induced acute renal failure is associated with an increase in the cytokines interleukin (IL)-1beta, IL-18, IL-6, and neutrophil infiltration in the kidney. J Pharmacol Exp Ther. 2007;322(1):8–15. doi:10.1124/jpet.107.119792
   PubMed Web of Science ®Google Scholar
• Ramesh G, Reeves WB. Salicylate reduces cisplatin nephrotoxicity by inhibition of tumor necrosis factor-alpha. Kidney Int. 2004;65(2):490–499. doi:10.1111/j.1523-1755.2004.00413.x
   PubMed Web of Science ®Google Scholar
• Zeng L, Lin L, Xiao W, Li Y. L-theanine protects rat kidney from D-galactose-induced injury via inhibition of the AGEs/RAGE signaling pathway. Eur J Pharmacol. 2022;927:175072. doi:10.1016/j.ejphar.2022.175072
   PubMed Web of Science ®Google Scholar
• Shen C, Ma Y, Zeng Z, Yin Q, Hong Y, Hou X and Liu X. (2017). RAGE-Specific Inhibitor FPS-ZM1 Attenuates AGEs-Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia. Neurochem Res, 42(10), 2902–2911. 10.1007/s11064-017-2321-x
   PubMed Web of Science ®Google Scholar
• Giridharan VV, Thandavarayan RA, Bhilwade HN. Schisandrin B, attenuates cisplatin-induced oxidative stress, genotoxicity and neurotoxicity through modulating NF-κB pathway in mice. Free Radic Res. 2012;46(1):50–60. doi:10.3109/10715762.2011.638291
   PubMed Web of Science ®Google Scholar
• Gao X, Wang J, Wang Y . Fucoidan-ferulic acid nanoparticles alleviate cisplatin-induced acute kidney injury by inhibiting the cGAS-STING pathway. Int J Biol Macromol. 2022;223(Pt A):1083–1093. doi:10.1016/j.ijbiomac.2022.11.062
   PubMedGoogle Scholar
• Peiro G, Alary J, Cravedi JP, Rathahao E, Steghens JP, Guéraud F. Dihydroxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation. Biofactors. 2005;24(1–4):89–96. doi:10.1002/biof.5520240110
   PubMed Web of Science ®Google Scholar
• Ansari MA. Sinapic acid modulates Nrf2/HO-1 signaling pathway in cisplatin-induced nephrotoxicity in rats. Biomed Pharmacother. 2017;93:646–653. doi:10.1016/j.biopha.2017.06.085
   PubMed Web of Science ®Google Scholar
• Zhao W, Li J, Li Y, Chen Y, Jin H. Preventive effect of collagen peptides from acaudina molpadioides on acute kidney injury through attenuation of oxidative stress and inflammation. Oxid Med Cell Longev. 2022;2022:8186838. doi:10.1155/2022/8186838
   PubMed Web of Science ®Google Scholar
• Diao C, Chen Z, Qiu T, et al. Inhibition of PRMT5 attenuates oxidative stress-induced pyroptosis via activation of the Nrf2/HO-1 signal pathway in a mouse model of renal ischemia-reperfusion injury. Oxid Med Cell Longev. 2019;2019:2345658. doi:10.1155/2019/2345658
   PubMed Web of Science ®Google Scholar
• Tran MT, Zsengeller ZK, Berg AH, et al. PGC1α drives NAD biosynthesis linking oxidative metabolism to renal protection. Nature. 2016;531(7595):528–532. doi:10.1038/nature17184
   PubMed Web of Science ®Google Scholar